Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera

Citation
Mp. Sandler et al., Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera, J NUCL MED, 39(12), 1998, pp. 2035-2043
Citations number
69
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
Journal title
JOURNAL OF NUCLEAR MEDICINE
ISSN journal
01615505 → ACNP
Volume
39
Issue
12
Year of publication
1998
Pages
2035 - 2043
Database
ISI
SICI code
0161-5505(199812)39:12<2035:FCIUAM>2.0.ZU;2-B
Abstract
Conventional Tl-201 and hexakis 2-methoxy-2-isobutyl isonitrile studies are less accurate as compared to FDG PET in the prediction of functional recov ery after revascularization in patients with injured but viable myocardium. The introduction of a dual-head variable-angle-geometry scintillation came ra equipped with thicker crystals (5/8 in.) and high-resolution, ultrahigh- energy collimators capable of 511 keV imaging has permitted FDG SPECT to pr ovide information equivalent to that of PET for the detection of injured bu t viable myocardium in patients with chronic ischemic heart disease. The de velopment of standardized glucose-loading protocols, including glucose-insu lin-potassium infusion and the potential use of nicotinic acid derivatives, has simplified the method of obtaining consistently good-to-excellent qual ity FDG SPECT cardiac studies. FDG SPECT may become the modality of choice for evaluating injured but viable myocardium because of enhanced availabili ty of FDG, logistics, patient convenience, accuracy and cost-effectiveness compared to PET.